loader from loading.io

IDH mutant glioma and IDH inhibitors

Neuro-Oncology: The Podcast

Release Date: 07/05/2024

Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas show art Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas

Neuro-Oncology: The Podcast

Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled “Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas”, published online in Neuro-Oncology in October 2025.

info_outline
Introduction to Neuro-Oncology: The Podcast 2.0 show art Introduction to Neuro-Oncology: The Podcast 2.0

Neuro-Oncology: The Podcast

In this episode, Dr. Evan Noch and Dr. Maya Graham discuss the exciting new podcast subtypes and the episodes to come.

info_outline
Radiotherapy induced neurocognitive decline show art Radiotherapy induced neurocognitive decline

Neuro-Oncology: The Podcast

Description: Dr. Iyad Alnahhas interviews Dr. Charlotte Sleurs about her and her team's recent manuscript entitled: "Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach", published online in Neuro-Oncology in May 2025.

info_outline
QOL and cognitive functioning in patients with oligodendroglioma show art QOL and cognitive functioning in patients with oligodendroglioma

Neuro-Oncology: The Podcast

Dr. Iyad Alnahhas interviews Drs. Florien Boele and Martin Klein about their recent manuscript entitled: “Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation”, published online in Neuro-Oncology in July 2025.

info_outline
Post-operative radiation in recurrent grade 1 meningiomas show art Post-operative radiation in recurrent grade 1 meningiomas

Neuro-Oncology: The Podcast

Dr. Iyad Alnahhas interviews Drs. Felix Sahm and Maximilian Deng about their recent manuscript entitled: "Postoperative radiotherapy in subtotally-resected recurrent WHO grade 1 meningiomas with intermediate/ high-risk molecular profiles", published online in Neuro-Oncology in May 2025.

info_outline
mRNA CAR T against GD2 in high-grade glioma models show art mRNA CAR T against GD2 in high-grade glioma models

Neuro-Oncology: The Podcast

Dr. Maya Graham interviews Dr. Jessica Foster about her and her team's recent manuscript, entitled "Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models". This work was published online in Neuro-Oncology in May 2025.

info_outline
A transcriptomic atlas of CNS tumors show art A transcriptomic atlas of CNS tumors

Neuro-Oncology: The Podcast

Dr. Evan Noch interviews Dr. Akshitkumar Mistry about his and his team's recent manuscript entitled "A clinically annotated transcriptomic atlas of nervous system tumors", published online in Neuro-Oncology in May 2025 Link to the paper:

info_outline
Gut microbiome in primary CNS lymphoma show art Gut microbiome in primary CNS lymphoma

Neuro-Oncology: The Podcast

Dr. Iyad Alnahhas interviews Drs. Isaias Hernandez-Verdin and Agusti Alentorn about their recent manuscript entitled: "Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial", published online in Neuro-Oncology in March 2025   Link: 

info_outline
Germline analysis of diffuse midline glioma show art Germline analysis of diffuse midline glioma

Neuro-Oncology: The Podcast

Dr. Evan Noch interviews Dr. Marion Mateos about her and her team's recent manuscript entitled: "Germline analysis of an international cohort of pediatric diffuse midline glioma patients", published online in Neuro-Oncology in March 2025.

info_outline
The proteomic landscape of diffuse midline glioma show art The proteomic landscape of diffuse midline glioma

Neuro-Oncology: The Podcast

Dr. Iyad Alnahhas interviews Drs. Cynthia Hawkins and Arun Vadivel about their recent manuscript entitled: "The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases", published online in Neuro-Oncology in February 2025.  

info_outline
 
More Episodes

Dr. Maya Graham interviews Dr. Martin van den Bent about his and his team's recent review article entitled "The biological significance of age, enhancement, extent of resection and tumor grade in IDH mutant gliomas: how should they inform treatment decision in the era of IDH inhibitors? Invited review", published online in Neuro-Oncology in